| mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-07 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |